Periodic Reporting for period 1 - NICHILD (Feasibility of a secretome factory to treat paediatric interstitial lung disease)

Despite their astonishing clinical success on adults, there are still no mesenchymal stem cell (MSC)-based products approved for paediatric use. Preclinical studies support a potential beneficial role of MSCs therapy to prevent progression of diseases called childhood...